David Planchard/oncostream.com
Apr 4, 2025, 20:12
David Planchard: A pleasure to discuss diagnostic and therapeutic advances in EGFR lung patients in Cannes
David Planchard, Thoracic Oncologist, Professor at University Paris Saclay and Head of Thoracic Cancer Group at Gustave Roussy, shared a post on LinkedIn:
“A pleasure to have shared the podium in Cannes with Pr P.Hofman to discuss diagnostic and therapeutic advances in EGFR lung patients….important role of combination with chemotherapy (brain mets, high tumor burden, ctDNA, L858R…), TKIs and ADCs coming…”
More posts featuring David Planchard.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 30, 2025, 17:20
Apr 30, 2025, 15:03
Apr 30, 2025, 14:11
Apr 30, 2025, 13:49
Apr 30, 2025, 13:39